News
Sepracor Announces Passing of Board Member James G. Andress
MARLBOROUGH, Mass.-(Business Wire)-March 14, 2008 - Sepracor Inc. (Nasdaq: SEPR) announced today that James G. Andress, a member of its Board of Directors, has passed away.
"We are extremely saddened by James' passing," said Adrian Adams, President and Chief Executive Officer of Sepracor. "James served on Sepracor's Board since 1991 and offered tremendous support, guidance and leadership. He will be greatly missed by our organization. On behalf of Sepracor, we extend our sincere condolences to his family."
Mr. Andress' business experience and acumen made him a sought-after and respected advisor. He served on many boards including AOL, Genetics Institute, Liposome, OptionCare; and most recently Sepracor, Allstate, Dade-Behring, Xoma, and Warner Chilcott. He also served on Northwestern University's Kellogg advisory committee and the board of Lake Forest College.
About Sepracor
Sepracor Inc. is a research-based pharmaceutical company dedicated to treating and preventing human disease by discovering, developing and commercializing innovative pharmaceutical products that are directed toward serving unmet medical needs. Sepracor's drug development program has yielded a portfolio of pharmaceutical products and candidates with a focus on respiratory and central nervous system disorders. Sepracor's corporate headquarters are located in Marlborough, Massachusetts. For a copy of this release or any recent release, visit Sepracor's web site at www.sepracor.com.
Search Our News Using Google Search
Can't find what you want? Try using Google:
